GAM
ALDR

Gemmer Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Gemmer Asset Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-125
Closed -$1K – 1303
2017
Q2 		$1K Hold
125
– – ﹤0.01% 1232
2017
Q1 		$3K Buy
+125
New +$2.77K ﹤0.01% 1151
2016
Q4 		– Sell
-125
Closed -$4K – 1267
2016
Q3 		$4K Hold
125
– – ﹤0.01% 1001
2016
Q2 		$3K Hold
125
– – ﹤0.01% 1120
2016
Q1 		$3K Hold
125
– – ﹤0.01% 1013
2015
Q4 		$4K Hold
125
– – ﹤0.01% 942
2015
Q3 		$4K Hold
125
– – ﹤0.01% 927
2015
Q2 		$7K Buy
+125
New +$4.55K ﹤0.01% 739

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Gemmer Asset Management's ALDR Position: Q3 2017 in Review

Gemmer Asset Management sold out of Alder Biopharmaceuticals (ALDR) in Q3 2017, closing a stake of 125 shares — an estimated $1K sold.

Gemmer Asset Management first reported a position in ALDR in Q2 2015 and held it in 8 quarters. The position peaked at $7K in Q2 2015. 132 funds tracked by Wall St. Rank hold ALDR as of Q3 2017.

  • Gemmer Asset Management reported no remaining Alder Biopharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Gemmer Asset Management sold 125 Alder Biopharmaceuticals shares in Q3 2017, an estimated $1K.
  • Gemmer Asset Management first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 8 quarters.
  • Gemmer Asset Management's Alder Biopharmaceuticals position peaked at $7K in Q2 2015.
  • 132 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2017.

Based on Gemmer Asset Management's 13F filing for Q3 2017, filed 12 Oct 2017.